VEGFA and ischemia: We are still at the beginning, but the application of pharmacological and molecular approaches for the characterization of distinct AMPA receptor membrane domains as well as their interaction with other hypoxia-related factors, such as vascular endothelial growth factor [58] may represent a valuable therapeutic tool for hypoxia-related disorders such as ischemia.